Safely Produce a Live Rabies Vaccine
Attenuation Strategies for Live Rabies Vaccine
Tags: University of Melbourne, Australia, Healthcare & Lifesciences
Researchers found a strategy for a live, safe rabies vaccine, overcoming inactivated vaccines' limits. By mutating a protein in the lyssavirus, they've developed a vaccine strain that's safe and effective in vivo. This innovation meets a critical need, with rabies causing nearly 59,000 deaths yearly. Live vaccines, unlike inactivated ones, are easier to produce and more immunogenic. This breakthrough could lead to a 'best in class' rabies vaccine.
IP Type or Form Factor: Patent Pending; Platform
TRL: Not specified
Industry or Tech Area: Vaccines; Biotechnology
